that improve lives, fuelled by market, customer, patient insight and intelligence.
Zebra26 is an evidence‑led consultancy that fuses commercial strategy, deep‑dive insights and patient‑centred outcomes to help pharma, biotech and med‑tech decision makers win at every stage of development.
Backed by 80 years of combined experience, our senior team sizes markets, profiles stakeholders and translates real‑world patient perspectives into actionable plans that de‑risk decisions and accelerate growth. We’re purpose‑built for healthcare focused companies, flexing with your needs while delivering straight‑talking, data‑driven advice that powers brand and portfolio success from concept to launch and beyond.
Evidence‑led services helping pharma, biotech & med‑tech teams turn insight and patient-centred outcomes into launch‑ready strategy
Zebra 26 converts real-world experience of healthcare audiences and rigorous analytics into decision-ready evidence, so decision makers can act without the guesswork.
Commercial Insights and Strategy
Zebra 26 turns evidence into advantage for pharma, biotech and med‑tech innovators by sizing markets, profiling customers and mapping competitors, then converting those insights into launch‑ready strategy.
We support building the brand by helping businesses anticipate, create and deliver products, devices and services that consumers and customers need and want.
Patient-centred outcomes: We uncover and convert patient & HCP insights and outcomes into validated PRO/ClinRO endpoints and product/ device-label language aligned to regulator requirements.